TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

3.20$ +9.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADAG
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
95.2% 98.1% 93.9% 98.1% 98.0% 98.0% 98.3% 98.9%
29.5% 87.4% 89.2% 92.0% 94.3% 95.0% 95.4% 95.2%
90.2% 94.9% 89.2% 92.0% 94.3% 95.0% 95.4% 95.2%
2.6% 2.0% 0.2% 4.0% 0.4% 0.2% 0.0% 0.0%
– 0.0% – 0.0% – – – –
4.7% 1.8% 2.5% 1.8% 2.0% – – –
175.4% 153.8% 206.1% 17.4% 45.5% 39.0% 43.4% 54.8%
19.0% 6.8% 19.2% 15.7% 36.1% 27.2% 42.8% 32.2%
4.3% 1.0% 6.0% 2.4% 9.0% 7.4% 20.1% 6.5%
1.0% 0.7% 2.1% 1.8% 2.4% 2.7% 4.8% 3.7%
– 1.4% 3.5% 1.6% 9.3% 11.7% 0.5% 1.5%
-75.4% -53.8% -106.1% 82.6% 54.5% 61.0% 56.6% 45.2%
-86.0% -59.7% -125.4% -94.4% -169.8% -240.0% -348.6% -420.1%
17.8% 33.4% 33.3% 16.9% 22.7% 30.3% 40.4% 48.3%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?